scholarly article | Q13442814 |
P356 | DOI | 10.1038/JHG.2015.120 |
P698 | PubMed publication ID | 26490187 |
P50 | author | Keiichi Koshizuka | Q86533788 |
Naohiko Seki | Q90079422 | ||
Hideki Enokida | Q90787285 | ||
P2093 | author name string | Yoshitaka Okamoto | |
Masayuki Nakagawa | |||
Rika Nishikawa | |||
Ryosuke Matsushita | |||
Yusuke Goto | |||
Toyoyuki Hanazawa | |||
Akira Kurozumi | |||
Naoko Kikkawa | |||
Ichiro Fukumoto | |||
Mayuko Kato | |||
P2860 | cites work | The role of miR-26 in tumors and normal tissues (Review) | Q24629056 |
Circulating tumour cells in metastatic head and neck cancers | Q26858916 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Extracellular matrix as target for antitumor therapy | Q28082018 | ||
Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma | Q28118099 | ||
miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer | Q28236303 | ||
Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer | Q30009425 | ||
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. | Q33559304 | ||
The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1 | Q33673803 | ||
Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature | Q33918123 | ||
miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). | Q34130721 | ||
Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. | Q34163575 | ||
Distribution volumes of macromolecules in human ovarian and endometrial cancers--effects of extracellular matrix structure | Q48254850 | ||
Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma | Q34208496 | ||
LOXL2 in epithelial cell plasticity and tumor progression | Q34303455 | ||
Current management strategy of hypopharyngeal carcinoma | Q34308054 | ||
Lysyl hydroxylase 3 glucosylates galactosylhydroxylysine residues in type I collagen in osteoblast culture | Q34684864 | ||
Hypoxia and the extracellular matrix: drivers of tumour metastasis | Q34820282 | ||
Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. | Q35527142 | ||
MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways | Q35678702 | ||
MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma | Q35869684 | ||
Microenvironmental control of the breast cancer cell cycle | Q35922924 | ||
Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin β₃ affinity modulation. | Q36166788 | ||
Metastatic bladder cancer cells distinctively sense and respond to physical cues of collagen fibril-mimetic nanotopography | Q36191451 | ||
HSP47 regulates ECM accumulation in renal proximal tubular cells induced by TGF-β1 through ERK1/2 and JNK MAPK pathways | Q36309370 | ||
Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study | Q36468724 | ||
The role of microRNAs in cancer: no small matter. | Q36832677 | ||
Integrins and metastasis | Q37014793 | ||
MicroRNAs--micro in size but macro in function | Q37255242 | ||
MicroRNAs in cancer: small molecules with a huge impact | Q37474280 | ||
Activation of the NOTCH pathway in head and neck cancer | Q37621332 | ||
Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions | Q37681322 | ||
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery | Q37974164 | ||
The rationale for targeting the LOX family in cancer | Q38027412 | ||
microRNAs are important players in head and neck carcinoma: a review | Q38129177 | ||
MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas | Q38178272 | ||
Diverse roles of miR-29 in cancer (review). | Q38191459 | ||
Human lysyl oxidase-like 2. | Q38242121 | ||
MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications | Q38413091 | ||
Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma | Q38861461 | ||
Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. | Q38973071 | ||
Protein O-fucosyltransferase 1: a potential diagnostic marker and therapeutic target for human oral cancer | Q39092173 | ||
LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients. | Q39112374 | ||
Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma | Q39243346 | ||
Functional analysis of LOXL2 in pancreatic carcinoma | Q39763088 | ||
Oral cancer cells with different potential of lymphatic metastasis displayed distinct biologic behaviors and gene expression profiles | Q39813090 | ||
New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. | Q42239363 | ||
Lysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma. | Q42720975 | ||
P433 | issue | 2 | |
P921 | main subject | microRNA | Q310899 |
P304 | page(s) | 109-118 | |
P577 | publication date | 2015-10-22 | |
P1433 | published in | Journal of Human Genetics | Q6295302 |
P1476 | title | Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma | |
P478 | volume | 61 |
Q91650451 | Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis |
Q33728303 | Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs |
Q38771636 | Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma. |
Q49218679 | Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma |
Q47912856 | Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma. |
Q38723997 | Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer |
Q47568135 | MiR-29a: a potential therapeutic target and promising biomarker in tumors |
Q49790324 | MicroRNA-26a and Tumor |
Q98782032 | MicroRNA-29a functions as a tumor suppressor through targeting STAT3 in laryngeal squamous cell carcinoma |
Q92444215 | MicroRNAs and Metastasis |
Q38726489 | Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer |
Q38754000 | Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis |
Q91643917 | Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma |
Q39384713 | Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma. |
Q38765720 | Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer. |
Q48301918 | Role of non-coding RNAs in head and neck squamous cell carcinoma: A narrative review. |
Q33740486 | Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma |
Q64064521 | The Role of MicroRNAs in Recurrence and Metastasis of Head and Neck Squamous Cell Carcinoma |
Q38936321 | The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma. |
Q101410380 | microRNAs deregulation in head and neck squamous cell carcinoma |
Search more.